Solid Biosciences Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Solid Biosciences Inc. (SLDB) had Operating Leases, Future Minimum Payments, Due in Three Years of $1.42 million as of 2019-12-31, per its 10-K filed 2021-03-15.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2021-03-15
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.42M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $2.06M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.01M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.00M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2019-12-31 | $1.42M 10-K · filed 2021-03-15 |
| 2018-12-31 | $2.06M 10-K · filed 2020-03-12 |
| 2018-09-30 | $2.01M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.00M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $2.00M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |